Phase Ib Trial of Immunotherapy/IL-2-Cytotoxic Cells

Mastrangelo, Michael J.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: Division of Cancer Treatment (NCI)
• Type: Research and Development Contracts (N01)
• Project #: N01CM067902-001001
• Application #: 3614385
• Project Start: 1987-07-31
• Budget Start: 1987-09-25
• Budget End: 1988-11-29
• Fiscal Year: 1987

Institution

• Name: Thomas Jefferson University
• Type: Schools of Medicine
• DUNS #: 061197161
• City: Philadelphia
• State: PA
• Country: United States
• Zip Code: 19107

Publications

Maguire Jr, H C; Berd, D; Lattime, E C et al. (1998) Phase I study of R24 in patients with metastatic melanoma including evaluation of immunologic parameters. Cancer Biother Radiopharm 13:13-23